News 2 Nov 2026 Project to develop dengue treatment pre-selected by the Global Coalition for Local and Regional Production, Innovation, and Equitable Access
Press releases 29 Oct 2026 DNDi welcomes GHIT Fund’s support for innovative approaches to improve success in Chagas disease drug discovery with Nagasaki University, the University of Dundee, and Eisai
Scientific articles 27 Oct 2026 Strengthening health systems and clinical development capacities through effective partnerships: a case study of DNDi’s collaboration with the Leishmaniasis Research and Treatment Center in Ethiopia (2003–2022) Frontiers in Tropical Diseases
Scientific articles 26 Oct 2026 Efficacy and safety of oxfendazole in adults with Trichuris spp. infection in Pemba Island, Tanzania: a double-blind, phase 2a, randomised controlled trial eClinicalMedicine
Scientific articles 22 Oct 2026 Deconvoluting the mode of action of antileishmanial aminopyrazoles through chemical mutagenesis Nature communications
Scientific articles 10 Oct 2026 Rethinking Clinical Trial Design to Accelerate Therapeutics for Arboviral Epidemics Open Forum Infectious Diseases
News 9 Oct 2026 DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness
Scientific articles 9 Oct 2026 A Perspective on Biomarkers, Candidates for Surrogate End Points to Accelerate Successful Development of New Antiparasitic Agents for the Treatment of Chronic Chagas Disease ACS Infectious Diseases
Press releases 6 Oct 2026 Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
Scientific articles 22 Sep 2026 Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial The Lancet Infectious Diseases
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
Press releases 29 Sep 2020 DRC: The Ministry of Health and DNDi launch a project designed to facilitate access to new treatments against sleeping sickness
Press releases 28 Sep 2020 Fundación MEDINA, DNDi, and Institut Pasteur Korea announce new funding from “la Caixa” Health Research for research partnership to discover new natural products against leishmaniasis and Chagas disease
Press releases 4 Sep 2020 Innovative single-dose oral sleeping sickness treatment to be co-developed by Sanofi and DNDi partnership
Press releases 13 May 2020 DNDi short film about new treatment for sleeping sickness awarded Grand Prix at inaugural WHO film festival
Press releases 14 Apr 2020 Up to 45,000 people living with Chagas disease in the US at risk of severe COVID-19 complications
Press releases 13 Apr 2020 Marking World Chagas Day for the first time to help give visibility to this neglected disease
Press releases 2 Apr 2020 Coalition launched to accelerate research on the prevention and treatment of COVID-19 in low- and middle-income countries
Press releases 25 Feb 2020 Novartis and DNDi to collaborate on the development of a new oral drug to treat visceral leishmaniasis
Press releases 5 Dec 2019 Brazil’s Ministry of Health and CNPq to invest in researching new treatments for leishmaniasis and Chagas disease
Press releases 28 Nov 2019 Public-private partnership launched to develop new drugs for roundworm infections
Press releases 27 Nov 2019 Research for new drugs against neglected diseases and malaria in Brazil to receive funding boost totaling BRL 43.5 million
Press releases 25 Nov 2019 Efforts to register new hepatitis C treatment in Malaysia receive support from Pharmaniaga
Press releases 25 Nov 2019 DNDi receives $29 million to fast-track the development of drugs to help eliminate sleeping sickness and river blindness
Press releases 20 Nov 2019 Study shows that African eye worm threatens elimination of river blindness
Press releases 30 Oct 2019 Not-for-profit research and development can address deadly market failure for neglected patients, paper shows
